Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma

from Neuro-Oncology: The Podcast · host Shahad Abdulsahib

Host/Interviewee: ç, PhD Candidate, UT Health San Antonio Description: Shahad Abdulsahib discusses the GT-20 phase 1 clinical trial evaluating GNOS-PV01, a personalized multivalent neoantigen DNA vaccine administered following surgical resection and radiation in patients with MGMT unmethylated glioblastoma, with findings published in Nature Cancer on May 12th, 2026.

Episode metadata supplied by the publisher feed · Published May 30, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma

0:00 3:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 3 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on May 30, 2026.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!